Navigating Market Access Hurdles

Is Medicare plan switching influenced by initial type of Medicare coverage and cancer history?

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city to be named at a later date.

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

How practical is this form of pricing in the pharma setting?

The acquisition of Cryoport’s specialty courier business is now finalized, with a value of approximately $200 million.